Ischemic preconditioning fails to confer additional protection against ischemia-reperfusion injury in the hypothyroid rat heart

Physiological Research

Volumn 58, Issue 1, 2009, Pages 29-38

  Mourouzis, I ^a   Dimopoulos, A ^a   Saranteas, T ^a   Tsinarakis, N ^a   Livadarou, E ^a   Spanou, D ^a   Kokkinos, A D ^a   Xinaris, C ^a   Pantos, C ^a   Cokkinos, D V ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Hypothyroidism; Ischemic preconditioning; JNKs; Myocardial ischemia; p38 MAPK; Thyroid hormone

Indexed keywords

CARDIAC MYOSIN; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROPYLTHIOURACIL; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CONVALESCENCE; DISEASE MODEL; ENZYMOLOGY; HEART CONTRACTION; HEART INFARCTION PREVENTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART VENTRICLE PRESSURE; HYPOTHYROIDISM; MALE; METABOLISM; PATHOPHYSIOLOGY; PERFUSION; PHOSPHORYLATION; RAT; REPERFUSION INJURY; TREATMENT FAILURE; WISTAR RAT;

ANIMALS; CARDIAC MYOSINS; DISEASE MODELS, ANIMAL; HYPOTHYROIDISM; ISCHEMIC PRECONDITIONING, MYOCARDIAL; JNK MITOGEN-ACTIVATED PROTEIN KINASES; L-LACTATE DEHYDROGENASE; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERFUSION; PHOSPHORYLATION; PROPYLTHIOURACIL; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; TREATMENT FAILURE; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 66549130238     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Abe M, Obata H, Tanaka H: Functional and metabolic responses to ischemia in the isolated perfused hypothyroid rat heart. Jpn Circ J 56: 671-680, 1992.
2. ATP channels. J Cardiovasc Electrophysiol 10: 741-754, 1999.
3. Bogoyevitch MA, Gillespie-Brown J, Ketterman AJ, Fuller SJ, Ben-Levy R, Ashworth A, Marshall CJ, Sugden PH: Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ Res 79: 162-173, 1996.
4. Das DK, Maulik N: Cardiac genomic response following preconditioning stimulus. Cardiovasc Res 70: 254-263, 2006.
5. Duplain H: Salvage of ischemic myocardium: a focus on JNK. Adv Exp Med Biol 588: 157-164, 2006.
6. Eynan M, Knubuvetz T, Meiri U, Navon G, Gerstenblith G, Bromberg Z, Hasin Y, Horowitz M: Heat acclimation-induced elevated glycogen, glycolysis, and low thyroxine improve heart ischemic tolerance. J Appl Physiol 93: 2095-2104, 2002.
7. Friberg L, Werner S, Eggertsen G, Ahnve S: Rapid down-regulation of thyroid hormones in acute myocardial infarction: is it cardioprotective in patients with angina? Arch Intern Med 162: 1388-1394, 2002
8. Hadour G, Ferrera R, Sebbag L, Forrat R, Delaye J, De Lorgeril M: Improved myocardial tolerance to ischaemia in the diabetic rabbit. J Mol Cell Cardiol 30: 1869-1875, 1998.
9. 3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation 107: 708-713, 2003.
10. Knight RJ, Buxton DB: Stimulation of c-Jun kinase and mitogen-activated protein kinase by ischemia and reperfusion in the perfused rat heart. Biochem Biophys Res Commun 218: 83-88, 1996.
11. Koneru S, Penumathsa SV, Thirunavukkarasu M, Samuel SM, Zhan L, Han Z, Maulik G, Das DK, Maulik N: Redox regulation of ischemic preconditioning is mediated by the differential activation of caveolins and their association with eNOS and GLUT-4. Am J Physiol 292: H2060-H2072, 2007.
12. Kristiansen SB, Lofgren B, Stottrup NB, Khatir D, Nielsen-Kudsk JE, Nielsen TT, Botker HE, Flyvbjerg A: Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes. Diabetologia 47: 1716-1721, 2004.
13. Mackay K, Mochly-Rosen D: An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia. J Biol Chem 274: 6272-6279, 1999.
14. Marais E, Genade S, Huisamen B, Strijdom JG, Moolman JA, Lochner A: Activation of p38 MAPK induced by a multi-cycle ischaemic preconditioning protocol is associated with attenuated p38 MAPK activity during sustained ischaemia and reperfusion. J Mol Cell Cardiol 33: 769-778, 2001.
15. Pantos CI, Cokkinos DD, Tzeis SM, Malliopoulou V, Mourouzis IS, Carageorgiou HC, Limas C, Varonos DV, Cokkinos DV: Hyperthyroidism is associated with preserved preconditioning capacity but intensified and accelerated ischaemic contracture in rat heart. Basic Res Cardiol 94: 254-260, 1999.
16. Pantos CI, Malliopoulou VA, Mourouzis IS, Karamanoli EP, Paizis IA, Steimberg N, Varonos DD, Cokkinos DV: Long-term thyroxine administration protects the heart in a pattern similar to ischemic preconditioning. Thyroid 12: 325-329, 2002.
17. Pantos C, Malliopoulou V, Mourouzis I, Moraitis P, Tzeis S, Thempeyioti A, Paizis I, Cokkinos A, Carageorgiou H, Varonos DD, Cokkinos DV: Involvement of p38 MAPK and JNK in heat stress-induced cardioprotection. Basic Res Cardiol 98: 158-164, 2003a.
18. Pantos C, Malliopoulou V, Mourouzis I, Sfakianoudis K, Tzeis S, Doumba P, Xinaris C, Cokkinos AD, Carageorgiou H, Varonos DD, Cokkinos DV: Propylthiouracil-induced hypothyroidism is associated with increased tolerance of the isolated rat heart to ischaemia-reperfusion. J Endocrinol 178: 427-435, 2003b.
19. Pantos C, Malliopoulou V, Paizis I, Moraitis P, Mourouzis I, Tzeis S, Karamanoli E, Cokkinos DD, Carageorgiou H, Varonos D, Cokkinos DV: Thyroid hormone and cardioprotection: study of p38 MAPK and JNKs during ischaemia and at reperfusion in isolated rat heart. Mol Cell Biochem 242: 173-180, 2003c.
20. Pantos C, Malliopoulou V, Mourouzis I, Karamanoli E, Moraitis P, Tzeis S, Paizis I, Cokkinos AD, Carageorgiou H, Varonos DD, Cokkinos DV: Thyroxine pretreatment increases basal myocardial heat-shock protein 27 expression and accelerates translocation and phosphorylation of this protein upon ischaemia. Eur J Pharmacol 478: 53-60, 2003d.
21. Pantos C, Malliopoulou V, Varonos DD, Cokkinos DV: Thyroid hormone and phenotypes of cardioprotection. Basic Res Cardiol 99: 101-120, 2004.
22. Pantos C, Mourouzis I, Saranteas T, Paizis I, Xinaris C, Malliopoulou V, Cokkinos DV: Thyroid hormone receptors alpha1 and beta1 are downregulated in the post-infarcted rat heart: consequences on the response to ischaemia-reperfusion. Basic Res Cardiol 100: 422-432, 2005a.
23. Pantos C, Mourouzis I, Malliopoulou V, Paizis I, Tzeis S, Moraitis P, Sfakianoudis K, Varonos DD, Cokkinos DV: Dronedarone administration prevents body weight gain and increases tolerance of the heart to ischemic stress: a possible involvement of thyroid hormone receptor alpha1. Thyroid 15: 16-23, 2005b.
24. Pantos C, Malliopoulou V, Mourouzis I, Thempeyioti A, Paizis I, Dimopoulos A, Saranteas T, Xinaris C, Cokkinos DV: Hyperthyroid hearts display a phenotype of cardioprotection against ischemic stress: a possible involvement of heat shock protein 70. Horm Metab Res 38: 308-313, 2006.
25. Pantos C, Mourouzis I, Cokkinos DV: Protection of the abnormal heart. Heart Fail Rev 12: 319-330, 2007a.
26. Pantos C, Mourouzis I, Dimopoulos A, Markakis K, Panagiotou M, Xinaris C, Tzeis S, Kokkinos AD, Cokkinos DV: Enhanced tolerance of the rat myocardium to ischemia and reperfusion injury early after acute myocardial infarction. Basic Res Cardiol 102: 327-333, 2007b.
27. Pantos C, Dritsas A, Mourouzis I, Dimopoulos A, Karatasakis G, Athanassopoulos G, Mavrogeni S, Manginas A, Cokkinos DV: Thyroid hormone is a critical determinant of myocardial performance in patients with heart failure: potential therapeutic implications. Eur J Endocrinol 157: 515-520, 2007c.
28. Pantos C, Mourouzis I, Xinaris C, Kokkinos AD, Markakis K, Dimopoulos A, Panagiotou M, Saranteas T, Kostopanagiotou G, Cokkinos DV: Time-dependent changes in the expression of thyroid hormone receptor alpha 1 in the myocardium after acute myocardial infarction: possible implications in cardiac remodelling. Eur J Endocrinol 156: 415-424, 2007d.
29. Ravingerová T, Barančík M, Strnisková M: Mitogen-activated protein kinases: a new therapeutic target in cardiac pathology. Mol Cell Biochem 247: 127-138, 2003.
30. Reiser PJ, Kline WO: Electrophoretic separation and quantitation of cardiac myosin heavy chain isoforms in eight mammalian species. Am J Physiol 274: H1048-H1053, 1998.
31. Sato M, Cordis GA, Maulik N, Das DK: SAPKs regulation of ischemic preconditioning. Am J Physiol 279: H901-H907, 2000.
32. Singh S, Duggal J, Molnar J, Maldonado F, Barsano CP, Arora R: Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis. Int J Cardiol 2007.
33. Tsai BM, Wang M, March KL, Turrentine MW, Brown JW, Meldrum DR: Preconditioning: evolution of basic mechanisms to potential therapeutic strategies. Shock 21: 195-209, 2004.
34. Valen G: Cellular signalling mechanisms in adaptation to ischemia-induced myocardial damage. Ann Med 35: 300-307, 2003.
35. Wang P, Chatham JC: Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart. Am J Physiol 286: E725-E736, 2004.
36. Xu G, Takashi E, Kudo M, Ishiwata T, Naito Z: Contradictory effects of short- and long-term hyperglycemias on ischemic injury of myocardium via intracellular signaling pathway. Exp Mol Pathol 76: 57-65, 2004.
37. Yin T, Sandhu G, Wolfgang CD, Burrier A, Webb RL, Rigel DF, Hai T, Whelan J: Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J Biol Chem 272: 19943-19950, 1997.
38. Zhang L, Parratt JR, Beastall GH, Pyne NJ, Furman BL: Streptozotocin diabetes protects against arrhythmias in rat isolated hearts: role of hypothyroidism. Eur J Pharmacol 435: 269-276, 2002.